HealthTechLilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCareBy Fierce Biotech
HealthTechKyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snagsBy Fierce Biotech